Laboratory Corp. of America Holdings plans to spin off its unit focused on clinical drug trials, according to people familiar with the matter, a move that will create a new stand-alone company in the fast-growing contract-research sector.
Burlington, N.C.-based Labcorp is expected to unveil the plan to separate its clinical-development business Thursday when it reports its second-quarter results, the people said. Labcorp will continue its focus on its core diagnostic-testing business and will also retain two related pieces of its drug-development unit, the people said.
Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más: